These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 318003)

  • 1. [Cefuroxim. Importance of beta-lactamase resistance, evaluated in vitro and in vivo].
    Xerri L; Orsolini P; Erani E; Broggio R
    G Ital Chemioter; 1979; 26(1-2):285-90. PubMed ID: 318003
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental infections for the evaluation of beta-lactamase resistance.
    Xerri L; Orsolini P; Erani E; Broggio R
    Antimicrob Agents Chemother; 1982 Feb; 21(2):201-3. PubMed ID: 6978673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A beta-lactamase from Proteus vulgaris that hydrolyses newly introduced cephalosporins.
    Pagani L; Perduca M; Romero E
    Microbiologica; 1983 Apr; 6(2):163-8. PubMed ID: 6306402
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer.
    Scioli C; Esposito S; Martinelli R
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):338-47. PubMed ID: 6335045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance of gram negative bacteria to new generation cephalosporins and the role of beta-lactamases in this type of resistance].
    Gür D; Akalin HE; Baykal M
    Mikrobiyol Bul; 1988; 22(3):193-8. PubMed ID: 3266970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter.
    Livermore DM; Woodford N
    Trends Microbiol; 2006 Sep; 14(9):413-20. PubMed ID: 16876996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactamase activity and cross-resistance to different cephalosporins of in vitro selected cefamandole-resistant variants of Enterobacter cloacae.
    Vuye A
    J Pharm Belg; 1982; 37(4):267-72. PubMed ID: 6982969
    [No Abstract]   [Full Text] [Related]  

  • 11. Living with ESBLs. Introduction.
    Cornaglia G; Garau J; Livermore DM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():1-2. PubMed ID: 18154523
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new method for evaluation of beta-lactamase production of resistant enterobacteriaceae strains (author's transl)].
    Schassan HH
    Zentralbl Bakteriol Orig A; 1978; 242(3):347-54. PubMed ID: 371259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-spectrum beta-lactamases.
    Turner PJ
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S273-5. PubMed ID: 16032564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefuroxime: antimicrobial activity, Pharmacology, and clinical efficacy.
    Smith BR; LeFrock JL
    Ther Drug Monit; 1983 Jun; 5(2):149-60. PubMed ID: 6349019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Review [new antibiotics series I]: cefuroxime (author's transl)].
    Nakagawa K
    Jpn J Antibiot; 1982 Feb; 35(2):283-95. PubMed ID: 7045446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins.
    Betriu C; Salso S; Sánchez A; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
    Int J Antimicrob Agents; 2006 Jul; 28(1):1-5. PubMed ID: 16769202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between beta-lactamases production and resistance to beta-lactam antibiotics in clinical isolates of Enterobacteriaceae.
    Romero E; Pagani L; Perduca M; Mignatti P; Malfa S; Mills V
    Microbiologica; 1984 Jul; 7(3):209-18. PubMed ID: 6334220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-generation cephalosporins resistance in clinical isolates of Enterobacteriaceae.
    Perduca M; Pagani L; Cereda PM; Debiaggi M
    Microbiologica; 1986 Apr; 9(2):199-207. PubMed ID: 3487023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
    Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.
    Raquet X; Lamotte-Brasseur J; Fonzé E; Goussard S; Courvalin P; Frère JM
    J Mol Biol; 1994 Dec; 244(5):625-39. PubMed ID: 7990143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.